Related Experiment Videos
CD8 cells play a critical role in delayed type hypersensitivity to intact Cryptococcus neoformans
1Department of Internal Medicine, University of Calgary, Alberta, Canada.
Journal of Immunology (Baltimore, Md. : 1950)
|April 15, 1994
Summary
CD8 cells are essential for the delayed type hypersensitivity (DTH) response to Cryptococcus neoformans, crucial for host defense. This study highlights CD8 cells
Area of Science:
- Immunology
- Microbiology
- Cellular Immunity
Background:
- Cell-mediated immunity is vital for host defense against Cryptococcus neoformans.
- The specific roles of T lymphocyte subsets, particularly CD8 cells, in this response are not fully understood.
- Delayed type hypersensitivity (DTH) is a key correlate of host defense against C. neoformans.
Purpose of the Study:
- To elucidate the mechanism by which CD8 cells participate in the DTH response to C. neoformans.
- To determine the necessity of CD8 cells during immunization, challenge, and effector phases of DTH.
Main Methods:
- Mice were immunized with live or heat-killed C. neoformans via intratracheal or subcutaneous routes, respectively.
- CD8 cells were depleted in vivo using monoclonal antibodies (mAb) before or after immunization.
- DTH response was assessed by footpad swelling after challenge with soluble cryptococcal antigen.
- Adoptive transfer experiments using splenocytes from CD8-depleted mice were performed.
Main Results:
- Mice depleted of CD8 cells before or after immunization failed to mount a DTH response.
- Splenocytes from CD8-depleted mice could not transfer DTH to naive recipients.
- CD8 cell depletion did not affect DTH responses to non-cryptococcal antigens (e.g., SRBC) mediated by CD4 cells.
Conclusions:
- CD8 cells are critically required for the induction, elicitation, and expression of DTH to C. neoformans.
- These findings suggest CD8 cells play a significant role in the cell-mediated immune response to C. neoformans.
- Targeting CD8 cell-stimulating immunotherapies may offer protection for individuals with CD4 cell deficiencies, such as in AIDS.